ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in ImageneBio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +10 vs. Q3 2021
- Shares held
- 27.4M
- +6.51M (+31.2%) vs. Q3 2021
- Total value
- $343.6M
- +$71.8M (+26.4%) vs. Q3 2021
- New holders
- 13
- 25 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62.9M | 5.78% | +5,018,178 | New |
| FMR LLC | 4,723,687 | $59.2M | 0.00% | −307,453−6.1% | Reduced |
| OrbiMed Advisors LLC | 2,933,941 | $36.8M | 0.48% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,249,123 | $28.2M | 3.99% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,128,148 | $26.7M | 0.03% | +1,0630.0% | Added |
| BVF Inc | 1,798,371 | $22.6M | 0.82% | −33,700−1.8% | Reduced |
| Artal Group S.A. | 1,549,513 | $19.4M | 0.57% | 00.0% | Unchanged |
| BlackRock Inc. | 1,363,877 | $17.1M | 0.00% | +879,946+181.8% | Added |
| Farallon Capital Management, L.L.C. | 1,081,309 | $13.6M | 0.08% | −36,040−3.2% | Reduced |
| CHI Advisors LLC | 814,756 | $10.2M | 3.39% | +499,756+158.7% | Added |
| Vanguard Group Inc | 782,394 | $9.81M | 0.00% | +161,708+26.1% | Added |
| Ra Capital Management, L.P. | 750,000 | $9.40M | 0.17% | 00.0% | Unchanged |
| State Street Corp | 340,614 | $4.27M | 0.00% | +208,146+157.1% | Added |
| Logos Global Management LP | 299,853 | $3.76M | 0.39% | 00.0% | Unchanged |
| HealthCor Management, L.P. | 287,621 | $3.61M | 0.20% | −52,330−15.4% | Reduced |
| Geode Capital Management, LLC | 284,454 | $3.57M | 0.00% | +89,993+46.3% | Added |
| Northern Trust Corp | 208,065 | $2.61M | 0.00% | +116,308+126.8% | Added |
| Ensign Peak Advisors, Inc | 127,810 | $1.60M | 0.00% | +27,810+27.8% | Added |
| Victory Capital Management Inc | 112,330 | $1.41M | 0.00% | +20,790+22.7% | Added |
| Nuveen Asset Management, LLC | 72,793 | $997.0K | 0.00% | +39,709+120.0% | Added |
| Bank of New York Mellon Corp | 77,862 | $977.0K | 0.00% | +54,988+240.4% | Added |
| Charles Schwab Investment Management Inc | 63,534 | $797.0K | 0.00% | +38,230+151.1% | Added |
| Qube Research & Technologies Ltd | 42,788 | $537.0K | 0.00% | +42,788 | New |
| Rhumbline Advisers | 28,102 | $352.0K | 0.00% | +28,102 | New |
| Bank of America Corp | 24,642 | $309.0K | 0.00% | +13,720+125.6% | Added |
| Millennium Management LLC | 17,333 | $217.0K | 0.00% | +17,333 | New |
| Deutsche Bank AG | 16,838 | $211.0K | 0.00% | +10,864+181.9% | Added |
| California State Teachers Retirement System | 15,147 | $190.0K | 0.00% | +10,301+212.6% | Added |
| American International Group, Inc. | 14,725 | $185.0K | 0.00% | +9,038+158.9% | Added |
| Wells Fargo & Company | 14,607 | $184.0K | 0.00% | +385+2.7% | Added |
| Susquehanna International Group, LLP | 14,567 | $183.0K | 0.00% | +14,567 | New |
| Manufacturers Life Insurance Company, The | 13,936 | $175.0K | 0.00% | +13,936 | New |
| New York State Common Retirement Fund | 13,684 | $172.0K | 0.00% | +5,895+75.7% | Added |
| JPMorgan Chase & Co | 13,690 | $172.0K | 0.00% | +9,710+244.0% | Added |
| Goldman Sachs Group Inc | 12,864 | $161.0K | 0.00% | +12,864 | New |
| Morgan Stanley | 12,140 | $153.0K | 0.00% | +8,909+275.7% | Added |
| MetLife Investment Management | 11,742 | $147.2K | 0.00% | +11,742 | New |
| ProShare Advisors LLC | 11,111 | $138.0K | 0.00% | +11,111 | New |
| SG Americas Securities, LLC | 9,353 | $117.0K | 0.00% | +9,353 | New |
| Citigroup Inc | 9,057 | $114.0K | 0.00% | +7,692+563.5% | Added |
| Metropolitan Life Insurance Co | 8,698 | $109.1K | 0.00% | +8,698 | New |
| Royal Bank of Canada | 5,747 | $72.0K | 0.00% | +4,252+284.4% | Added |
| Baystate Wealth Management LLC | 2,999 | $38.0K | 0.00% | +2,999 | New |
| Legal & General Group Plc | 2,273 | $29.0K | 0.00% | +1,341+143.9% | Added |
| Ameritas Investment Partners, Inc. | 2,142 | $27.0K | 0.00% | +1,431+201.3% | Added |
| STRS Ohio | 2,100 | $26.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,755 | $22.0K | 0.00% | +1,009+135.3% | Added |
| Captrust Financial Advisors | 113 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 105 | $1.00K | 0.00% | +105 | New |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −199,781−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −85−100.0% | Sold out |